• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Synchroneuron

edit

Synchroneuron Inc., a Waltham, Mass.-based biopharmaceutical company that develops new therapies for tardive dyskinesia (TD) and other related movement disorders.

Milestones

edit

• 
  Synchroneuron received $6M in Series A funding. (2/6/12)
  Posted 2/6/12 at 6:44pm via finsmes.com

Videos

Screenshots

edit

Sources

1. Synchroneuron Closes $6M Series A Financing with Morningside Technology Ventures (finsmes.com) [edit]